PHILADELPHIA CHROMOSOME POSITIVE CML
Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE CML explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE CML trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo may let some CML patients stop treatment
Disease control OngoingThis study tests whether a strong drug (ponatinib) given first for 6 months, followed by a standard drug (imatinib), can help adults with newly diagnosed chronic myeloid leukemia reach a deep remission. The goal is to see if patients can then safely stop all treatment. About 170 …
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE CML
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
Promising new leukemia drug trial for kids shows hope
Disease control OngoingThis study is testing a drug called bosutinib in children with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). The goal is to find the best dose and see if it is safe and works for children who are newly diagnosed or whose cancer has not responded to other tr…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE CML
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 20, 2026 11:56 UTC